Traduire
Le projet EMBOBIO reçoit le prix de l’innovation AP-HM 2022
NEOSTEM : soigner l’encéphalopathie anoxo-ischémique du nouveau-né grâce à la thérapie cellulaire
Spreading safe, cheap embolization around the world
Le CERIMED, une plate-forme d’imagerie transversale, interdisciplinaire et fédératrice
R&D
Located on the Marseille-Timone Campus, CERIMED is an innovative multidisciplinary working environment opened to academics and SME for the development and validation of novel medical imaging techniques and protocols.
Services
CERIMED offers its equipments and knowledge in the form of a range of service offers for academics and industries. Each CERIMED department may contribute to development and validation of your innovative medical imaging techniques and protocols.
Training
Implement a transversal way of learning and training, meeting the various concerned disciplines (physics, biology, medicine, radiopharmacy, ...) and the industry, but also offer a theoretical and practical training to the medical imaging techniques.
Recent Posts
-
Symposium’23 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30 - 3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
- FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
- Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
- Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Dernières Publications (5/477)
- Sarrade, A, El Allam, J, Espinas, V, Hoffart, L, Picard, C, David, T et al.. Fast and compact scatterometer for ex vivo qualification of low-scattering biological samples. Rev Sci Instrum. 2026;97 (7):. doi: 10.1063/5.0327390. PubMed PMID:42439722 .
- Guedj, E, Beckman, D. Dopaminergic vulnerability in long COVID: striatal PET imaging at the brain-body interface. EBioMedicine. 2026; :106369. doi: 10.1016/j.ebiom.2026.106369. PubMed PMID:42431744 .
- Baboudjian, M, Barret, E, Brureau, L, Fiard, G, Fromont, G, Olivier, J et al.. Evidence Thresholds for Novel Therapeutic Strategies in Prostate Cancer: A Consensus Statement from the Prostate Cancer Committee of the French Urological Association. Fr J Urol. 2026; :103162. doi: 10.1016/j.fjurol.2026.103162. PubMed PMID:42413772 .
- Guedj, E, Newberg, AB, Alavi, A. Future Directions for [18F]FDG PET in Central Nervous System Diseases. PET Clin. 2026; :. doi: 10.1016/j.cpet.2026.06.003. PubMed PMID:42409693 .
- Guedj, E, Newberg, AB, Alavi, A. How Fluorine-18-labeled Fluorodeoxyglucose PET Changed Clinical Practice in Central Nervous System Disorders. PET Clin. 2026; :. doi: 10.1016/j.cpet.2026.06.002. PubMed PMID:42409692 .